Since the first case of COVID-19 in Latin America and the Caribbean was reported in Brazil on February 26, 2020, the region has reported more than 25.4 million cases and 800,000 COVID-related deaths. Countries have actively worked to secure vaccines through bilateral and multilateral arrangements, including agreements with Pfizer, Moderna, AstraZeneca, Russia’s Sputnik V, and China’s CoronaVac.
The following interactive maps track, among other things, the percentage of the population of each Latin American and Caribbean country covered by current vaccine agreements; the total number of doses secured by each country and breakdown by supplier/vaccine; and, where each vaccine is being used across the region. The interactive maps are updated on a biweekly basis.
Percentage of population of Latin American countries covered by current vaccine agreements
Percentage of population of Caribbean nations covered by current vaccine agreements
Number of vaccine doses secured per Latin American country under current agreements
Number of vaccine doses secured per Caribbean nation under current agreements
Amidst some of the highest infection and death rates in the world, companies from seven countries have delivered vaccines to the region: China, Russia, India, the United States, the United Kingdom, Germany, and Sweden. Through donations of vaccines and medical supplies and loan commitments, China, Russia, and India are quickly becoming the partners of choice in the region’s COVID-19 recovery.
After Mexican President Andrés Manuel López Obrador thanked India and Russia for helping Mexico access COVID-19 vaccines, in breaking news, the Biden administration announced it would send 2.5 million doses of the AstraZeneca vaccine to Mexico. The plan marks the first time the United States directly supplies vaccines to another country.
As the geopolitics of vaccine and pandemic assistance plays out, our tracker shows how widespread each vaccine is across Latin America and the Caribbean, and how many vaccines flow from each major producing country (country of origin of the vaccine maker) to regional destinations.
Where each vaccine is being used in Latin America
The map below demonstrates the flow of vaccines by the manufacturer’s main country of origin to Latin American and Caribbean countries covered by current vaccine agreements.